[Ovid] Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer Patients Treated With Neoadjuvant Chemotherapy |
|
This post will be closed automatically in 2026-06-16 01:37
Reward10points
|
10
Conjoined Twin Separation: Review of 30-Year Case Experience and Lessons Learned
10
Superiorly Based Short-Scar Mastopexy Augmentation: A 10-Year Review of 1217 Consecutive Cases
10
Modern methods of dorsal augmentation rhinoplasty
10
Improving facial scar outcomes: an evidence-based update
30
Male and Female Master Rowers Physiologically Resilient to Repeated Maximal Efforts?
